Healthcare Triangle, Inc. (NASDAQ:HCTI) ("HCTI" or the "Company"), a U.S.-based healthcare technology company, today announced that it has signed on as the U.S. technology and capital-markets partner for a new fund built to move Malaysian healthcare companies to the world stage. The Kanzun-ARCB Growth Fund launched through a Memorandum of Understanding signed in Kuala Lumpur, Malaysia, pairing Dubai-based ARCB Investment LLC's ("ARCB") capital network with Kanzun Ventures Management Sdn. Bhd.'s ("Kanzun") deal experience on the ground in Malaysia. HCTI's role will be to get qualifying companies ready, technologically and financially, for a successful run at the U.S. capital markets.

ARCB brings roughly AED 300 million in assets under management and a network of family offices, institutional investors and strategic partners across the Middle East and Asia. The firm opened its Asia-Pacific office in Kuala Lumpur in April 2026, and the Kanzun-ARCB Growth Fund marks its first major platform launch in the region. Together with Kanzun and HCTI, the three parties are building a structured corridor connecting Malaysian healthcare companies to Middle Eastern capital and, from there, to U.S. capital markets.